Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Fainted; Dizzy; This serious case was reported by a consumer via interactive digital media and described the occurrence of fainting in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 14-FEB-2025, the patient received the 1st dose of Shingles vaccine. In FEB-2025, an unknown time after receiving Shingles vaccine, the patient experienced fainting (Verbatim: Fainted) (serious criteria GSK medically significant) and dizziness (Verbatim: Dizzy). The outcome of the fainting was resolved and the outcome of the dizziness was not resolved. It was unknown if the reporter considered the fainting and dizziness to be related to Shingles vaccine. The company considered the fainting and dizziness to be unrelated to Shingles vaccine. Additional Information: GSK receipt Date: 15-FEB-2025 This case was reported by a patient via interactive digital media. The patient received shingles vaccine a day before reporting . Now, the patient was extremely dizzy and fainted once.; Sender's Comments: Syncope and Dizziness are unlisted events which are considered unrelated to GSK Shingles vaccine.